デフォルト表紙
市場調査レポート
商品コード
1440050

多血小板血漿(PRP)の世界市場:洞察、競合情勢、市場予測:2030年

Platelet Rich Plasma (PRP) - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
多血小板血漿(PRP)の世界市場:洞察、競合情勢、市場予測:2030年
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の多血小板血漿(PRP)の市場規模は、2023年に4億1,300万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に10.18%のCAGRで拡大し、2030年には7億3,600万米ドルに達すると予測されています。多血小板血漿(PRP)の需要は、主に整形外科疾患、スポーツ傷害、急性および慢性創傷、婦人科疾患、泌尿器科疾患などを患う患者の増加によって後押しされています。加えて、美容フェイシャル、顔の若返り、にきび跡、顔の瘢痕、フェイスリフトや隆起切除、隆鼻術、毛髪再生、脂肪移植などの様々な美容施術におけるPRPのニーズの高まり、製品の発売や承認の増加などが、2024年~2030年の予測期間中の多血小板血漿(PRP)市場の全体的な成長に寄与しています。

多血小板血漿(PRP)市場は、様々な要因によって製品需要が伸びていますが、その主要な要因の1つは、様々な治療適応症の普及率の増加です。

国際骨粗鬆症財団(2023年)によると、骨粗鬆症に関連する骨折は世界で年間890万件以上発生しています。同財団はさらに、50歳以上の男性の約5人に1人、女性の3人に1人が骨が弱いために骨折しやすいと述べています。

さらに、Osteoarthritis Action Alliance(OAAA)が発表したデータによると、2020年、2019年には、世界中で約2億4,200万人が、一般的な関節炎の1つである変形性関節症(OA)の症状や活動制限に苦しんでいます。また、2019年のデータでは、OA患者の約43%が65歳以上であり、OA患者の88%が45歳以上です。

当レポートでは、世界の多血小板血漿(PRP)市場について調査し、市場の概要とともに、製品タイプ別、PRPタイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 多血小板血漿(PRP)市場レポートのイントロダクション

第2章 多血小板血漿(PRP)市場のエグゼクティブサマリー

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 多血小板血漿(PRP)市場の主な要因分析

  • 多血小板血漿(PRP)市場の促進要因
  • 多血小板血漿(PRP)市場の抑制要因と課題
  • 多血小板血漿(PRP)市場の機会

第5章 多血小板血漿(PRP)市場におけるポーターのファイブフォース分析

第6章 多血小板血漿(PRP)市場に対するCOVID-19の影響分析

第7章 多血小板血漿(PRP)市場概要

  • 製品タイプ別
  • PRPタイプ別
  • 用途別
  • エンドユーザー別
  • 地域別

第8章 多血小板血漿(PRP)市場企業と製品プロファイル

  • Johnson & Johnson
  • Zimmer Biomet
  • Arthrex
  • Terumo Corporation
  • Stryker
  • Dr. PRP USA LLC.
  • Juventix Regenerative Medical, LLC.
  • EmCyte Corporation
  • Apex Biologix
  • Celling Biosciences
  • Isto Biologics
  • Exactech, Inc.
  • Nuo Therapeutics, Inc.
  • Regen Lab SA
  • CollPlant Biotechnologies Ltd.
  • Estar Technologies Ltd.
  • ELTEK S.P.A.
  • Royal Biologics
  • PRP Concepts
  • Crown

第9章 KOL の見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Platelet Rich Plasma (PRP) Market in Global (2021-2030)
  • Table 4: Platelet Rich Plasma (PRP) Market in Global by Product Type (2021-2030)
  • Table 5: Platelet Rich Plasma (PRP) Market in Global by PRP Type (2021-2030)
  • Table 6: Platelet Rich Plasma (PRP) Market in Global by Application (2021-2030)
  • Table 7: Platelet Rich Plasma (PRP) Market in Global by End-User (2021-2030)
  • Table 8: Platelet Rich Plasma (PRP) Market in Global by Geography (2021-2030)
  • Table 9: Platelet Rich Plasma (PRP) Market in North America (2021-2030)
  • Table 10: Platelet Rich Plasma (PRP) Market in North America by Country (2021-2030)
  • Table 11: Platelet Rich Plasma (PRP) Market in the US (2021-2030)
  • Table 12: Platelet Rich Plasma (PRP) Market in Canada (2021-2030)
  • Table 13: Platelet Rich Plasma (PRP) Market in Mexico (2021-2030)
  • Table 14: Platelet Rich Plasma (PRP) Market in Europe (2021-2030)
  • Table 15: Platelet Rich Plasma (PRP) Market in Europe by Country (2021-2030)
  • Table 16: Platelet Rich Plasma (PRP) Market in France (2021-2030)
  • Table 17: Platelet Rich Plasma (PRP) Market in Germany (2021-2030)
  • Table 18: Platelet Rich Plasma (PRP) Market in the United Kingdom (2021-2030)
  • Table 19: Platelet Rich Plasma (PRP) Market in Italy (2021-2030)
  • Table 20: Platelet Rich Plasma (PRP) Market in Spain (2021-2030)
  • Table 21: Platelet Rich Plasma (PRP) Market in the Rest of Europe (2021-2030)
  • Table 22: Platelet Rich Plasma (PRP) Market in Asia-Pacific (2021-2030)
  • Table 23: Platelet Rich Plasma (PRP) Market in Asia-Pacific by Country (2021-2030)
  • Table 24: Platelet Rich Plasma (PRP) Market in China (2021-2030)
  • Table 25: Platelet Rich Plasma (PRP) Market in Japan (2021-2030)
  • Table 26: Platelet Rich Plasma (PRP) Market in India (2021-2030)
  • Table 27: Platelet Rich Plasma (PRP) Market in Australia (2021-2030)
  • Table 28: Platelet Rich Plasma (PRP) Market in South Korea (2021-2030)
  • Table 29: Platelet Rich Plasma (PRP) Market in Rest of Asia-Pacific (2021-2030)
  • Table 30: Platelet Rich Plasma (PRP) Market in the Rest of the World (2021-2030)
  • Table 31: Platelet Rich Plasma (PRP) Market in RoW by Region (2021-2030)
  • Table 32: Platelet Rich Plasma (PRP) Market in the Middle East (2021-2030)
  • Table 33: Platelet Rich Plasma (PRP) Market in Africa (2021-2030)
  • Table 34: Platelet Rich Plasma (PRP) Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Platelet Rich Plasma (PRP) Market in Global (2021-2030)
  • Figure 4: Platelet Rich Plasma (PRP) Market in Global by Product Type (2021-2030)
  • Figure 5: Platelet Rich Plasma (PRP) Market in Global by PRP Type (2021-2030)
  • Figure 6: Platelet Rich Plasma (PRP) Market in Global by Application (2021-2030)
  • Figure 7: Platelet Rich Plasma (PRP) Market in Global by End-User (2021-2030)
  • Figure 8: Platelet Rich Plasma (PRP) Market in Global by Geography (2021-2030)
  • Figure 9: Platelet Rich Plasma (PRP) Market in North America (2021-2030)
  • Figure 10: Platelet Rich Plasma (PRP) Market in North America by Country (2021-2030)
  • Figure 11: Platelet Rich Plasma (PRP) Market in the US (2021-2030)
  • Figure 12: Platelet Rich Plasma (PRP) Market in Canada (2021-2030)
  • Figure 13: Platelet Rich Plasma (PRP) Market in Mexico (2021-2030)
  • Figure 14: Platelet Rich Plasma (PRP) Market in Europe (2021-2030)
  • Figure 15: Platelet Rich Plasma (PRP) Market in Europe by Country (2021-2030)
  • Figure 16: Platelet Rich Plasma (PRP) Market in France (2021-2030)
  • Figure 17: Platelet Rich Plasma (PRP) Market in Germany (2021-2030)
  • Figure 18: Platelet Rich Plasma (PRP) Market in the United Kingdom (2021-2030)
  • Figure 19: Platelet Rich Plasma (PRP) Market in Italy (2021-2030)
  • Figure 20: Platelet Rich Plasma (PRP) Market in Spain (2021-2030)
  • Figure 21: Platelet Rich Plasma (PRP) Market in the Rest of Europe (2021-2030)
  • Figure 22: Platelet Rich Plasma (PRP) Market in Asia-Pacific (2021-2030)
  • Figure 23: Platelet Rich Plasma (PRP) Market in Asia-Pacific by Country (2021-2030)
  • Figure 24: Platelet Rich Plasma (PRP) Market in China (2021-2030)
  • Figure 25: Platelet Rich Plasma (PRP) Market in Japan (2021-2030)
  • Figure 26: Platelet Rich Plasma (PRP) Market in India (2021-2030)
  • Figure 27: Platelet Rich Plasma (PRP) Market in Australia (2021-2030)
  • Figure 28: Platelet Rich Plasma (PRP) Market in South Korea (2021-2030)
  • Figure 29: Platelet Rich Plasma (PRP) Market in Rest of Asia-Pacific (2021-2030)
  • Figure 30: Platelet Rich Plasma (PRP) Market in the Rest of the World (2021-2030)
  • Figure 31: Platelet Rich Plasma (PRP) Market in RoW by Region (2021-2030)
  • Figure 32: Platelet Rich Plasma (PRP) Market in the Middle East (2021-2030)
  • Figure 33: Platelet Rich Plasma (PRP) Market in Africa (2021-2030)
  • Figure 34: Platelet Rich Plasma (PRP) Market in South America (2021-2030)
  • Figure 35: Market Drivers
  • Figure 36: Market Barriers
  • Figure 37: Marker Opportunities
  • Figure 38: PORTER'S Five Force Analysis
目次
Product Code: DISR0090

Platelet Rich Plasma (PRP) Market By Product Type (PRP Systems And PRP Kits), By PRP Type (Pure Platelet Rich Plasma, Leukocyte Rich Plasma, And Others), By Application (Orthopedic, Sports Medicine, Cosmetic Surgery, And Others), By End-User (Hospitals, Clinics, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising demand of platelet-rich plasma (PRP) therapy in various therapeutic applications and the increasing demand for non-surgical and minimally invasive therapy

Global platelet rich plasma (PRP) market was valued at USD 413 million in 2023, growing at a CAGR of 10.18% during the forecast period from 2024 to 2030 to reach USD 736 million by 2030. The demand for platelet rich plasma (PRP) is primarily being boosted by the increasing figures of patients suffering from orthopedic diseases, sports injuries, acute and chronic wounds, gynecological diseases, urological diseases, among other. In addition, the growing need of PRP in various aesthetic procedures such as cosmetic facials, facial rejuvenation, acne scars, facial scarring, facelift and rhytidectomy, rhinoplasty, hair restoration, fat grafting, and other aesthetic procedures, the increasing product launches and approval among others are thereby contributing to the overall growth of the platelet rich plasma (PRP) market during the forecast period from 2024-2030.

Platelet Rich Plasma (PRP) Market Dynamics:

The platelet rich plasma (PRP) market is witnessing a growth in product demand owing to various factors, one of the key factors being the increase in the prevalence of various therapeutic indications.

As per the International Osteoporosis Foundation (2023), over 8.9 million fractures related to osteoporosis occurs annually worldwide. It further stated that about one in five men and one in three women over the age of 50 are susceptible to suffer from a fracture due to weak bones.

Furthermore, as per the data published by the Osteoarthritis Action Alliance (OAAA), 2020, in the year 2019, about 242 million people worldwide suffered from symptomatic and activity limiting osteoarthritis (OA) which is one of the common types of arthritis. The data also mentioned that about 43% of people with OA are 65 or older and 88% of people with OA are 45 or older in 2019.

PRP can be used to treat osteoporosis, and can effectively manage pain in orthopedic disorders. Thus, the increasing prevalence of various orthopedic disease such as arthritis, tennis elbow, golfer's elbow, plantar fasciitis, rotator cuff injuries, and others, will increase the demand of PRP therapy, ultimately increasing the demand of PRP systems and kits used while doing PRP therapy.

The American Academy of Dermatology Association in a latest data stated that acne is the most common skin condition in the United States, affecting up to 50 million people annually. Also, according to International society of Aesthetic Plastic surgery 2022, nearly 20,128 rhinoplasty surgeries and 23,125 face fat grafting surgical procedures were performed in Japan, in 2022. The afore-said source also mentioned that approximately 16,776 rhinoplasty and 9,828 fat grafting surgeries were done in Spain, in 2022.

PRP therapy in case of fat grafts offers a better fat grafting survival, a less bruising and inflammation reaction, and easier application of fat grafts. Also, platelets rich plasma (PRP) is claimed to fasten healing process reducing postoperative edema, and bleeding, thus it have a wide application in various cosmetic procedures. Thus, the growing demand of PRP in various aesthetic procedures such as cosmetic facials, facial rejuvenation, acne scars, facial scarring, facelift and others, will create a positive impact on the market of platelet-rich plasma in the upcoming years.

Along with the facial procedures, PRP is also widely used for hair restoration. PRP can be used as a new therapeutic option for hair loss including androgenetic alopecia and female pattern hair loss, either as a monotherapy or an adjuvant to conventional therapy or hair transplantation.

Therefore, the above-mentioned factors are contributing to the growth of the platelet rich plasma (PRP) market during the forecast period from 2024-2030.

However, the presence of alternative treatment options, multiple session, leading to high cost of therapy, and others may restrict the platelet rich plasma (PRP) market growth.

The platelet rich plasma (PRP) market was significantly impacted during the period of COVID- 19 pandemic. The outbreak of the pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitalization and treatment procedures for various ailments such as orthopedic and sports injuries, gynecological, urological, cosmetic, and others. This resulted in the reduced number patients of routine treatments of the above mentioned disorders. Moreover, many elective surgeries were postponed as treatment of patients suffering from coronavirus infection was on priority. Additionally, the restrictions in supply chain, raw materials, and other resources halted the manufacturing of devices, leading to the shortage of devices and kits in the market. However, the vaccine development of COVID-19 initiated the process of economic recovery. Also, with the easing of lockdown restrictions and the return of normalcy in the economic landscape initiated the process of resumption of regular healthcare services such as outpatients visits for various treatments, therapies, and surgeries for the afore-mentioned ailments, thereby bringing the demand for products on track in the platelet rich plasma (PRP) market.

Platelet Rich Plasma (PRP) Market Segment Analysis:

Platelet Rich Plasma (PRP) Market by Product Type (PRP Systems and PRP Kits), PRP Type (Pure Platelet Rich Plasma, Leukocyte Rich Plasma, and Others), Application (Orthopedic, Sports Medicine, Cosmetic Surgery, and Others), End-User (Hospitals, Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the platelet rich plasma (PRP) market, the PRP systems category is expected to amass significant revenue share of 60% in the year 2023 growing at a CAGR of 10.46% during the forecast period from 2024-2030. This can be ascribed to the advantages and applications associated with PRP systems.

The commercially available PRP systems facilitate the preparation of ready to apply platelet-rich suspensions in a reproducible manner. These systems operate on a small volume of drawn blood and on the principle of centrifugation.

Depending on the method and time of its centrifugation, these systems differ widely in their ability to collect and concentrate platelets.

The PRP systems help to prepare suspensions of different concentration of platelets and leucocytes. For example, Arthrex ACP, a double-syringe system facilitate the safe and rapid preparation of autologous platelet-rich plasma (PRP) from a small sample of blood at the patient's point of care. The prepared PRP can be mixed with autograft and allograft bone prior to application to an orthopedic surgical site as per the need.

Also, the SmartPrep® 3 System by Terumo Corporation is used for producing autologous platelet-rich plasma (PRP) enriched with growth factors. The system has features such as cell capture technology, optimized platelet recovery, consistent results, high platelet concentrations, fast processing time, and volume flexibility.

The increasing technological advancements such as automation of PRP systems is likely to increase their demand. For instance, Angelina is the first completely automated blood centrifuge for autologous PRP generation developed by 2M Engineering. This device does full automatic concentration and extraction of thrombocyte or platelets from whole blood for a range of potential medical applications.

Therefore, the advantages offered by the PRP systems are predicted to contribute to the increasing demand for this product type thereby driving the growth of the overall platelet rich plasma (PRP) market during the forecast period.

North America is expected to dominate the overall Platelet Rich Plasma (PRP) Market:

Among all the regions, North America is estimated to account for the largest share of 43% in the platelet rich plasma (PRP) market in the year 2023. Owing to the factors such as the rising geriatric population, the growing incidents of traumatic injuries due to falls, accidents, and others, the growing number of orthopedic and cosmetic procedures, along with recent product launches in the region, the demand for PRP is expected to increase during the forecast period. Moreover, the rising physician and patient awareness about newly introduced treatment procedures and technologies, are expected to aid in the growth of the North America PRP market. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about ophthalmic diseases also helped the market growth in this region.

For instance, as per a report by the Centers for Disease Control and Prevention (CDC) (2023), more than 32.5 million people were affected with osteoarthritis in 2019, and is one of the most common form of joint disorders in the United States.

The American Academy of Orthopedic Surgeons, stated that each year, almost 2 million people in the United States visit doctors because of rotator cuff (RC) tears. In case of RC tear, PRP injections encourages the body's healing processes and rally the growth factors to increase regenerative capability at the place of injection.

Coupled with the factors mentioned above, strategic activities such as product launches and approvals, mergers, acquisitions, partnerships, and others also help in boosting regional product demand. For instance, in February 2023, Royal Biologics, a company specializing in Advanced Cellular Technologies & Enhanced Autologous Solutions, announced the commercial launch of BIOINCYTE(TM) PRFM, a next-generation PRP system, which converts traditional PRP to Platelet Rich Fibrin Matrix (PRFM) formulations. Thus, such strategic steps help to increase the demand for platelet rich plasma (PRP), thereby driving the North America platelet rich plasma (PRP) market forward during the forecast period.

Platelet Rich Plasma (PRP) Market Key Players:

Some of the key market players operating in the platelet rich plasma (PRP) market include Johnson & Johnson, Zimmer Biomet, Arthrex, Terumo Corporation, Stryker, Dr. PRP USA LLC., Juventix Regenerative Medical, LLC., EmCyte Corporation, Apex Biologix, Celling Biosciences, Isto Biologics, Exactech, Inc., Nuo Therapeutics, Inc., Regen Lab SA, CollPlant Biotechnologies Ltd., Estar Technologies Ltd., ELTEK S.P.A., Royal Biologics, PRP Concepts, Crown, and others.

Recent Developmental Activities in the Platelet Rich Plasma (PRP) Market:

In October 2022, i-Stem PRP Kit Platelet Rich Plasma Therapy was launched in the UK, which is a unique, modernized anti-shake patented i-Stem PRP System, for the safe and effective treatment within the exciting field of regenerative medicine, making treatment effective and simple.

In September 2022, Royal Biologics, an ortho-biologics company focused on Autologous and Live Cellular solutions, announced FDA 510K approval of their Maxx- PRP concentration system. The system is a patented next-generation concentration device that can be used to concentrate autologous whole blood for the safe and rapid preparation of platelet-rich plasma to use point of care for mixing with autograft and/or allograft to improve handling characteristics.

In February 2020, EmCyte, the world leader in platelet rich plasma and progenitor stem cell biologics, announced FDA 510(k) clearance for its PurePRP® Supraphysiologic Concentrating System for platelet rich plasma. The system is cleared to be used for the safe and rapid preparation of autologous platelet rich plasma (PRP) extracted from sample of blood at the patient's point of care.

Key Takeaways from the Platelet Rich Plasma (PRP) Market Report Study

Market size analysis for current platelet rich plasma (PRP) market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the platelet rich plasma (PRP) market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global platelet rich plasma (PRP) market.

Various opportunities available for the other competitor in the platelet rich plasma (PRP) market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current platelet rich plasma (PRP) market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for platelet rich plasma (PRP) market growth in the coming future?

Target Audience who can be benefited from this Platelet Rich Plasma (PRP) Market Report Study

Platelet rich plasma (PRP) products providers

Research organizations and consulting companies

Platelet rich plasma (PRP)-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in platelet rich plasma (PRP)

Various End-users who want to know more about the platelet rich plasma (PRP) market and the latest technological developments in the platelet rich plasma (PRP) market.

Frequently Asked Questions for the Platelet Rich Plasma (PRP) Market:

1. What is platelet rich plasma (PRP)?

Platelet-rich plasma (PRP) is an autologous conditioned plasma product derived from peripheral blood with inherent immunomodulatory and anabolic properties.

2. What is the market for global platelet rich plasma (PRP)?

Global platelet rich plasma (PRP) market was valued at USD 413 million in 2023, growing at a CAGR of 10.18% during the forecast period from 2024 to 2030 to reach USD 736 million by 2030.

3. What are the drivers for global platelet rich plasma (PRP) market?

The demand for platelet rich plasma (PRP) is primarily being heightened by the increasing prevalence of various therapeutic diseases such as orthopedic, gynecological, urological, and others. In addition, the surging demand of non-surgical and non-invasive surgeries across the globe, the increasing number of aesthetic procedures using PRP therapy, increasing product launches and approvals, among others, thereby contribute to the overall growth of the platelet rich plasma (PRP) market during the forecast period from 2024-2030.

4. Who are the key players operating in the global platelet rich plasma (PRP) market?

Some of the key market players operating in the platelet rich plasma (PRP) market include Johnson & Johnson, Zimmer Biomet, Arthrex, Terumo Corporation, Stryker, Dr. PRP USA LLC., Juventix Regenerative Medical, LLC., EmCyte Corporation, Apex Biologix, Celling Biosciences, Isto Biologics, Exactech, Inc., Nuo Therapeutics, Inc., Regen Lab SA, CollPlant Biotechnologies Ltd., Estar Technologies Ltd., ELTEK S.P.A., Royal Biologics, PRP Concepts, Crown, and others.

5. Which region has the highest share in the platelet rich plasma (PRP) market?

North America is expected to dominate the overall Platelet Rich Plasma (PRP) market during the forecast period from 2024-2030. Factors such as the upsurge in the ageing population susceptible to various disorders, rise in the number of osteoporosis cases, growing number of cosmetic surgeries, among others will positively impact the North American Platelet Rich Plasma (PRP) market. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about PRP therapy also helped the market growth in this region.

Table of Contents

1.Platelet Rich Plasma (PRP) Market Report Introduction

2. Platelet Rich Plasma (PRP) Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Platelet Rich Plasma (PRP) Market Key Factors Analysis

  • 4.1. Platelet Rich Plasma (PRP) Market Drivers
    • 4.1.1. Rising demand of Platelet-rich Plasma therapy in various therapeutic applications
    • 4.1.2. Growing need of PRP in aesthetic procedures
    • 4.1.3. Increasing demand for non-surgical and minimally invasive therapy
  • 4.2. Platelet Rich Plasma (PRP) Market Restraints and Challenges
    • 4.2.1. Presence of alternative treatment options
    • 4.2.2. Multiple session, leading to high cost of therapy
  • 4.3. Platelet Rich Plasma (PRP) Market Opportunities
    • 4.3.1. Need for more standardized PRP preparation protocols

5. Platelet Rich Plasma (PRP) Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Platelet Rich Plasma (PRP) Market

7. Platelet Rich Plasma (PRP) Market Layout

  • 7.1. By Product Type
    • 7.1.1. PRP Systems
    • 7.1.2. PRP Kits
  • 7.2. By PRP Type
    • 7.2.1. Pure Platelet Rich Plasma
    • 7.2.2. Leukocyte Rich Plasma
    • 7.2.3. Others
  • 7.3. By Application
    • 7.3.1. Orthopedic
    • 7.3.2. Sports Medicine
    • 7.3.3. Cosmetic Surgery
    • 7.3.4. Others
  • 7.4. By End-User
    • 7.4.1. Hospitals
    • 7.4.2. Clinics
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
      • 7.5.1.1. United States Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
      • 7.5.1.2. Canada Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
      • 7.5.1.3. Mexico Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
    • 7.5.2. Europe Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
      • 7.5.2.1. France Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
      • 7.5.2.2. Germany Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
      • 7.5.2.3. United Kingdom Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
      • 7.5.2.4. Italy Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
      • 7.5.2.5. Spain Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
      • 7.5.2.6. Rest of Europe Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
    • 7.5.3. Asia-Pacific Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
      • 7.5.3.1. China Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
      • 7.5.3.2. Japan Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
      • 7.5.3.3. India Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
      • 7.5.3.4. Australia Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
      • 7.5.3.5. South Korea Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
      • 7.5.3.6. Rest of the Asia-Pacific Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
    • 7.5.4. Rest of the World (RoW) Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
      • 7.5.4.1. Middle East Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
      • 7.5.4.2. Africa Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)
      • 7.5.4.3. South America Platelet Rich Plasma (PRP) Market Size in USD million (2021-2030)

8. Platelet Rich Plasma (PRP) Market Company and Product Profiles

  • 8.1. Johnson & Johnson
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Zimmer Biomet
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Arthrex
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Terumo Corporation
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Stryker
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Dr. PRP USA LLC.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Juventix Regenerative Medical, LLC.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. EmCyte Corporation
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Apex Biologix
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Celling Biosciences
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Isto Biologics
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Exactech, Inc.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Nuo Therapeutics, Inc.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Regen Lab SA
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. CollPlant Biotechnologies Ltd.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Estar Technologies Ltd.
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. ELTEK S.P.A.
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18 Royal Biologics
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. PRP Concepts
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Crown
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us